What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Mutation
The scientist’s investigation covers issues in Internal medicine, Genetics, Atrial fibrillation, Apixaban and Stroke.
His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology, Surgery and Cardiology.
His work on Mitochondrial DNA, Mutation, Point mutation and Episodic ataxia as part of general Genetics research is frequently linked to PRRT2, bridging the gap between disciplines.
His Atrial fibrillation research is multidisciplinary, incorporating perspectives in Randomized controlled trial, Proportional hazards model and Embolism.
His Apixaban research is classified as research in Warfarin.
His research integrates issues of Concomitant and Myocardial infarction in his study of Stroke.
His most cited work include:
- Apixaban versus Warfarin in Patients with Atrial Fibrillation (5705 citations)
- Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial (429 citations)
- Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. (405 citations)
What are the main themes of his work throughout his whole career to date?
Michael G. Hanna focuses on Internal medicine, Genetics, Pathology, Cardiology and Clinical neurology.
His Internal medicine research includes elements of Endocrinology and Periodic paralysis.
His work focuses on many connections between Atrial fibrillation and other disciplines, such as Stroke, that overlap with his field of interest in Proportional hazards model.
His Myotonia research includes themes of Channelopathy and Sodium channel.
He combines subjects such as Ataxia, Neuroscience and Epilepsy with his study of Episodic ataxia.
To a larger extent, he studies Warfarin with the aim of understanding Apixaban.
He most often published in these fields:
- Internal medicine (28.17%)
- Genetics (16.85%)
- Pathology (14.76%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (28.17%)
- Pathology (14.76%)
- Cardiology (9.59%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Pathology, Cardiology, Myotonia and Atrial fibrillation.
His work on Adverse effect as part of general Internal medicine study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Bioinformatics is closely connected to Skeletal muscle in his research, which is encompassed under the umbrella topic of Pathology.
His Myotonia research incorporates elements of Channelopathy, Periodic paralysis and Sodium channel.
While the research belongs to areas of Atrial fibrillation, Michael G. Hanna spends his time largely on the problem of Stroke, intersecting his research to questions surrounding Proportional hazards model.
His research links Hazard ratio with Apixaban.
Between 2016 and 2021, his most popular works were:
- Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches. (56 citations)
- Review of the Diagnosis and Treatment of Periodic Paralysis. (56 citations)
- Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy. (52 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Mutation
Michael G. Hanna mainly investigates Internal medicine, Atrial fibrillation, Cardiology, Apixaban and Stroke.
His study in Endocrinology extends to Internal medicine with its themes.
Michael G. Hanna has included themes like Mitral regurgitation, Sudden death, Incidence and Cause of death in his Atrial fibrillation study.
The study incorporates disciplines such as Diaphragmatic weakness, Lung volumes and Pulmonary function testing in addition to Cardiology.
His Apixaban study is concerned with the larger field of Warfarin.
His Stroke research integrates issues from Coagulation, Proportional hazards model, Heart failure and Fibrin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
